Case File №
#VI-2026-0636
Science
Request Full Data Access to the VendorInvestigator database of peptide tests.
Exhibit I
Compounds on File
43 LINE ITEMS| Compound | Grade | Samples | Mean | Min | Max | Latest |
|---|---|---|---|---|---|---|
| GHK-Cu | A Great | 4 | 7.2 | 6.5 | 7.6 | 20 May 2025 |
| BPC-157 | B Good | 4 | 6.8 | 5.9 | 7.3 | 16 May 2025 |
| PT-141 | C Okay | 2 | 5.7 | 5.6 | 5.8 | 21 May 2025 |
| Melanotan II | C Okay | 2 | 6.0 | 5.7 | 6.3 | 20 May 2025 |
| 17a-Methyl-1-Testosterone | X N/A | 1 | 7.1 | 7.1 | 7.1 | 16 Mar 2025 |
| 5-amino-1MQ | X N/A | 1 | 8.3 | 8.3 | 8.3 | 28 Mar 2025 |
| AHK-CU | X N/A | 1 | 7.2 | 7.2 | 7.2 | 16 Mar 2025 |
| BMK glycidic acid (P-2-P methyl glycidic acid / sodium salt) CAS 5449-12-7 | X N/A | 1 | 6.2 | 6.2 | 6.2 | 13 Jun 2025 |
| BPC-157 Arg Oral | X N/A | 1 | 9.8 | 9.8 | 9.8 | 24 Apr 2025 |
| BPC157 5mg + TB500 5mg Blend | X N/A | 1 | 4.0 | 3.9 | 3.9 | 13 Feb 2025 |
| Chonluten | X N/A | 1 | 7.1 | 7.1 | 7.1 | 13 Jun 2025 |
| CJC-1295 With DAC | X N/A | 1 | 7.3 | 7.3 | 7.3 | 14 Jan 2025 |
| CJC-1295 w/o DAC 10mg + IPA 10mg Blend | X N/A | 1 | 5.3 | 5.3 | 5.3 | 2 Jul 2025 |
| Dapoxetine | X N/A | 1 | 6.8 | 6.8 | 6.8 | 16 Mar 2025 |
| Dianabol Raw | X N/A | 1 | 4.2 | 4.2 | 4.2 | 24 Apr 2025 |
| Dianabol | X N/A | 1 | 4.9 | 4.9 | 4.9 | 16 Mar 2025 |
| EPO | X N/A | 1 | 6.3 | 6.3 | 6.3 | 13 Jun 2025 |
| Equipoise (Boldenone Undecylenate) | X N/A | 1 | 5.0 | 5.0 | 5.0 | 13 Feb 2025 |
| GLOW GHK-CU 35mg+TB500 10mg+BPC157 5mg | X N/A | 1 | 7.1 | 7.1 | 7.1 | 20 Jun 2025 |
| Hyaluronic acid | X N/A | 1 | 5.8 | 5.8 | 5.8 | 25 Apr 2025 |
| KLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg+KPV 10mg | X N/A | 1 | 7.6 | 7.6 | 7.6 | 2 Apr 2025 |
| Letrozole | X N/A | 1 | 8.2 | 8.2 | 8.2 | 3 Jul 2025 |
| LGD-4033 (Ligandrol) | X N/A | 1 | 5.2 | 5.2 | 5.2 | 8 Jul 2025 |
| Methylene Blue | X N/A | 1 | 7.0 | 7.0 | 7.0 | 16 Mar 2025 |
| MOTS-C | X N/A | 1 | 6.8 | 6.8 | 6.8 | 16 Mar 2025 |
| NA Semax Amidate | X N/A | 1 | 6.4 | 6.4 | 6.4 | 13 Feb 2025 |
| NAD+ | X N/A | 1 | 6.0 | 6.0 | 6.0 | 28 Mar 2025 |
| NandroMix 300 | X N/A | 1 | 5.7 | 5.7 | 5.7 | 9 Jun 2025 |
| Orforglipron | X N/A | 1 | 6.8 | 6.8 | 6.8 | 13 Feb 2025 |
| P2NP (1-phenyl-2-nitropropene) CAS 705-60-2 | X N/A | 1 | 7.1 | 7.1 | 7.1 | 3 Jun 2025 |
| PE 22-28 | X N/A | 1 | 6.2 | 6.2 | 6.2 | 3 Jun 2025 |
| Pinealon | X N/A | 1 | 5.8 | 5.8 | 5.8 | 8 Jul 2025 |
| Primobolan Oral (Methenolone Acetate) | X N/A | 1 | 9.6 | 9.6 | 9.6 | 2 Jul 2025 |
| Prostamax | X N/A | 1 | 8.5 | 8.5 | 8.5 | 9 Jun 2025 |
| Retatrutide 30mg Pen Kit | X N/A | 1 | 4.6 | 4.6 | 4.6 | 16 Mar 2025 |
| RIPEX 225 (TRA/Mast P/Test P) | X N/A | 1 | 6.2 | 6.2 | 6.2 | 3 Jul 2025 |
| Selank 10mg + Semax 10mg Blend | X N/A | 1 | 6.9 | 6.9 | 6.9 | 6 May 2025 |
| Semaglutide Oral | X N/A | 1 | 7.4 | 7.4 | 7.4 | 6 May 2025 |
| Sleep Blend (GABA 100mg+Histidine 100mg+L-Theanine 50mg+Taurine 100mg+Melatonin 2mg) | X N/A | 1 | 4.0 | 3.3 | 3.3 | 28 Mar 2025 |
| Superdrol | X N/A | 1 | 5.7 | 5.7 | 5.7 | 28 Mar 2025 |
| Tamoxifen (Nolvadex) Raw | X N/A | 1 | 7.4 | 7.4 | 7.4 | 28 Mar 2025 |
| Trenbolone Acetate | X N/A | 1 | 6.6 | 6.6 | 6.6 | 11 Jun 2025 |
| Vilon | X N/A | 1 | 8.0 | 8.0 | 8.0 | 16 Mar 2025 |
Exhibit II
Evidence Log
46 LABORATORY RETURNS| Filed | Compound | Score | Claimed | Found | Δ Qty | Purity | Batch № | Lab | Source |
|---|---|---|---|---|---|---|---|---|---|
| 25 May 2026 | Dianabol Raw | 4.0 C | 100g | 86.8g | -13.2% | 97.02% | jlhech | Lab C | Public |
| 25 May 2026 | Letrozole | 7.8 A | 20mg | 24.2mg | +21.2% | 96.87% | mvzmze | Lab F | Public |
| 24 May 2026 | BPC-157 Arg Oral | 9.6 A | 100mg | 114.1mg | +14.1% | 96.23% | k9y5yf | Lab F | Public |
| 24 May 2026 | Methylene Blue | 7.3 A | 50mg | 43.7mg | -12.6% | 95.65% | cwyt40 | Lab A | Public |
| 24 May 2026 | 17a-Methyl-1-Testosterone | 8.2 A | 50mg | 43.2mg | -13.7% | 97.77% | ftj9xl | Lab B | Public |
| 24 May 2026 | RIPEX 225 (TRA/Mast P/Test P) | 6.6 A | 250mg/ml | 275.9mg/ml | +10.3% | 97.57% | rorhb0 | Lab C | Community |
| 24 May 2026 | NA Semax Amidate | 5.3 B | 15mg | 18.2mg | +21.3% | 95.08% | 681zur | Lab E | Public |
| 24 May 2026 | P2NP (1-phenyl-2-nitropropene) CAS 705-60-2 | 7.2 A | 5g | 4.4g | -12.8% | 99.46% | 3wai37 | Lab C | Public |
| 24 May 2026 | Trenbolone Acetate | 8.3 A | 100mg/ml | 114.5mg/ml | +14.5% | 99.57% | ydjcho | Lab E | Community |
| 23 May 2026 | Pinealon | 4.0 C | 20mg | 24.3mg | +21.4% | 99.13% | c3hv5p | Lab A | Community |
| 21 May 2026 | NAD+ | 7.5 A | 5mg | 5.0mg | -0.7% | 95.78% | rtezu6 | Lab G | Public |
| 20 May 2026 | 5-amino-1MQ | 4.3 C | 10mg | 12.5mg | +24.6% | 95.14% | n5m9u6 | Lab E | Community |
| 20 May 2026 | Tamoxifen (Nolvadex) Raw | 7.9 A | 100g | 92.9g | -7.1% | 99.36% | iem463 | Lab B | Public |
| 19 May 2026 | BPC157 5mg + TB500 5mg Blend | 4.6 C | 50mg | 51.7mg | +3.4% | 96.95% | khau5v | Lab C | Public |
| 19 May 2026 | PE 22-28 | 7.2 A | 5mg | 5.7mg | +13.3% | 97.01% | gu49qa | Lab C | Public |
| 17 May 2026 | Dapoxetine | 5.5 B | 25mg | 21.3mg | -14.7% | 95.76% | cfju2u | Lab E | Public |
| 29 Jan 2026 | Equipoise (Boldenone Undecylenate) | 4.0 C | 100mg/ml | 95.8mg/ml | -4.2% | 96.59% | icbjp0 | Lab C | Community |
| 29 Jan 2026 | GLOW GHK-CU 35mg+TB500 10mg+BPC157 5mg | 7.1 A | 30mg | 26.7mg | -11.1% | 96.45% | 8ln7ob | Lab D | Public |
| 29 Jan 2026 | MOTS-C | 6.3 A | 50mg | 48.6mg | -2.9% | 95.50% | 338vct | Lab D | Community |
| 29 Jan 2026 | Selank 10mg + Semax 10mg Blend | 6.7 A | 2mg | 1.7mg | -14.9% | 96.97% | 9engv0 | Lab F | Public |
| 7 Jan 2026 | BMK glycidic acid (P-2-P methyl glycidic acid / sodium salt) CAS 5449-12-7 | 6.6 A | 100g | 106.3g | +6.3% | 97.64% | kkquo0 | Lab E | Public |
| 6 Jan 2026 | Chonluten | 6.9 A | 15mg | 17.6mg | +17.6% | 99.88% | 6nkoly | Lab D | Community |
| 29 Dec 2025 | Primobolan Oral (Methenolone Acetate) | 10.0 A | 20mg | 22.0mg | +10.1% | 99.22% | c4dlad | Lab D | Public |
| 29 Dec 2025 | Superdrol | 5.4 B | 10mg | 8.8mg | -12.2% | 99.07% | jcqmmp | Lab A | Community |
| 12 Dec 2025 | EPO | 4.0 C | 50mg | 58.0mg | +15.9% | 97.65% | nsqbz5 | Lab C | Community |
| 5 Dec 2025 | CJC-1295 With DAC | 5.9 B | 30mg | 32.7mg | +8.9% | 98.53% | 1lr74f | Lab F | Community |
| 5 Dec 2025 | Orforglipron | 5.2 B | 10mg | 10.0mg | +0.3% | 95.77% | 38r01g | Lab D | Community |
| 5 Dec 2025 | Sleep Blend (GABA 100mg+Histidine 100mg+L-Theanine 50mg+Taurine 100mg+Melatonin 2mg) | 4.0 C | 200mg/ml | 192.3mg/ml | -3.9% | 98.75% | n4d9ia | Lab G | Public |
| 23 Nov 2025 | LGD-4033 (Ligandrol) | 7.5 A | 10mg | 11.1mg | +10.7% | 97.76% | mw5jmo | Lab B | Public |
| 17 Nov 2025 | Hyaluronic acid | 5.7 B | 5mg | 4.7mg | -5.3% | 95.31% | ic7jh3 | Lab D | Public |
| 14 Nov 2025 | CJC-1295 w/o DAC 10mg + IPA 10mg Blend | 4.0 C | 20mg | 18.3mg | -8.6% | 96.31% | j74wyk | Lab B | Community |
| 5 Nov 2025 | KLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg+KPV 10mg | 8.9 A | 30mg | 31.2mg | +4.1% | 95.29% | 5fqr84 | Lab C | Public |
| 5 Nov 2025 | Prostamax | 8.7 A | 20mg | 23.0mg | +15.1% | 97.43% | sqzsv8 | Lab A | Community |
| 5 Nov 2025 | Vilon | 8.0 A | 5mg | 5.7mg | +14.4% | 96.15% | uhvg6x | Lab F | Community |
| 4 Nov 2025 | AHK-CU | 7.8 A | 10mg | 9.9mg | -0.9% | 95.45% | hhiizg | Lab G | Public |
| 4 Nov 2025 | Semaglutide Oral | 9.5 A | 20mg | 21.8mg | +8.8% | 96.72% | i52xk8 | Lab F | Community |
| 17 Oct 2025 | Dianabol | 4.0 C | 10mg | 8.8mg | -12.3% | 96.10% | zyfdqy | Lab F | Public |
| 9 Oct 2025 | NandroMix 300 | 6.0 A | 100mg/ml | 99.9mg/ml | -0.1% | 97.16% | l4o1zp | Lab E | Public |
| 9 Oct 2025 | Retatrutide 30mg Pen Kit | 5.7 B | 30mg | 26.5mg | -11.6% | 96.68% | c2wnzz | Lab F | Public |
| 10 Jul 2025 | GHK-Cu | 6.5 B | 150mg | 110mg | -26.7% | 99.72% | 241023-0203 | Lab E | VendorInvestigator |
| 10 Jul 2025 | GHK-Cu | 7.2 A | 150mg | 122mg | -18.7% | 99.91% | 241023-0203 | Lab E | VendorInvestigator |
| 21 May 2025 | PT-141 | 5.6 C | 8mg | 11.25mg | +40.6% | 99.44% | 241014-0110 | Lab D | VendorInvestigator |
| 21 May 2025 | PT-141 | 5.8 C | 8mg | 11.39mg | +42.4% | 99.55% | 241014-0110 | Lab D | VendorInvestigator |
| 20 May 2025 | GHK-Cu | 7.6 A | 150mg | 135.48mg | -9.7% | 99.52% | 241023-0203 | Lab D | VendorInvestigator |
| 20 May 2025 | BPC-157 | 7.3 A | 6mg | 6.54mg | +9.0% | 99.30% | 241023-1217 | Lab D | VendorInvestigator |
| 20 May 2025 | Melanotan II | 6.3 B | 8mg | 10.75mg | +34.4% | 99.67% | 240925-0110 | Lab D | VendorInvestigator |
— END OF EVIDENCE LOG —